StockData
Cencora, Inc. logo

Cencora, Inc. (COR) stock

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$350.56−6.38 (-1.79%)

Close on Nov 17, 2026Market cap $66.90BP/E 26.0Yield 0.63%

Cencora operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Cencora's operating income for the twelve months ending Jun 30, 2026 was $3.04B, up 11.1% year over year. For fiscal 2025 it was $2.63B, up 20.8% from the year before. Over ten years it grew 20.1% a year on average. The highest annual figure on record is $2.63B in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025$2.63B+20.8%
FY2024Sep 30, 2024$2.18B-7.1%
FY2023Sep 30, 2023$2.34B-1.1%
FY2022Sep 30, 2022$2.37B+0.5%
FY2021Sep 30, 2021$2.35B–
FY2020Sep 30, 2020-$5.14B-561.8%
FY2019Sep 30, 2019$1.11B-23.0%
FY2018Sep 30, 2018$1.44B+36.2%
FY2017Sep 30, 2017$1.06B-30.5%
FY2016Sep 30, 2016$1.53B+261.4%
FY2015Sep 30, 2015$422.22M-46.0%
FY2014Sep 30, 2014$782.09M-12.9%
FY2013Sep 30, 2013$898.40M-31.1%
FY2012Sep 30, 2012$1.30B+9.6%
FY2011Sep 30, 2011$1.19B+8.9%
FY2010Sep 30, 2010$1.09B+23.6%
FY2009Sep 30, 2009$883.75M+6.8%
FY2008Sep 30, 2008$827.86M+5.0%
FY2007Sep 30, 2007$788.74M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.12B+29.1%
Q2 FY2026CQ1 2026Mar 31, 2026$1.14B+10.3%
Q1 FY2026CQ4 2025Dec 31, 2025$760.45M+7.7%
Q4 FY2025CQ3 2025Sep 30, 2025$18.50M-85.4%
Q3 FY2025CQ2 2025Jun 30, 2025$867.65M+29.0%
Q2 FY2025CQ1 2025Mar 31, 2025$1.04B+87.3%
Q1 FY2025CQ4 2024Dec 31, 2024$706.25M-14.2%
Q4 FY2024CQ3 2024Sep 30, 2024$126.64M-73.4%
Q3 FY2024CQ2 2024Jun 30, 2024$672.48M+0.4%
Q2 FY2024CQ1 2024Mar 31, 2024$553.26M-1.3%
Q1 FY2024CQ4 2023Dec 31, 2023$822.88M+30.0%
Q4 FY2023CQ3 2023Sep 30, 2023$476.94M+4.9%
Q3 FY2023CQ2 2023Jun 30, 2023$670.13M+37.5%
Q2 FY2023CQ1 2023Mar 31, 2023$560.52M-28.2%
Q1 FY2023CQ4 2022Dec 31, 2022$633.14M-1.7%
Q4 FY2022CQ3 2022Sep 30, 2022$454.52M-19.1%
Q3 FY2022CQ2 2022Jun 30, 2022$487.30M-21.5%
Q2 FY2022CQ1 2022Mar 31, 2022$780.16M+25.0%
Q1 FY2022CQ4 2021Dec 31, 2021$644.41M+17.8%
Q4 FY2021CQ3 2021Sep 30, 2021$561.90M–
Q3 FY2021CQ2 2021Jun 30, 2021$620.73M+53.3%
Q2 FY2021CQ1 2021Mar 31, 2021$624.35M+101.7%
Q1 FY2021CQ4 2020Dec 31, 2020$547.23M+107.7%
Q4 FY2020CQ3 2020Sep 30, 2020-$6.11B-3499.2%
Q3 FY2020CQ2 2020Jun 30, 2020$404.83M-0.5%
Q2 FY2020CQ1 2020Mar 31, 2020$309.52M+550.7%
Q1 FY2020CQ4 2019Dec 31, 2019$263.44M-44.9%
Q4 FY2019CQ3 2019Sep 30, 2019$179.84M+16.7%
Q3 FY2019CQ2 2019Jun 30, 2019$406.69M+4.5%
Q2 FY2019CQ1 2019Mar 31, 2019$47.57M-90.1%
Q1 FY2019CQ4 2018Dec 31, 2018$477.82M+14.0%
Q4 FY2018CQ3 2018Sep 30, 2018$154.10M–
Q3 FY2018CQ2 2018Jun 30, 2018$389.20M+128.4%
Q2 FY2018CQ1 2018Mar 31, 2018$481.42M-23.0%
Q1 FY2018CQ4 2017Dec 31, 2017$418.97M+4.7%
Q4 FY2017CQ3 2017Sep 30, 2017-$135.00M-160.1%
Q3 FY2017CQ2 2017Jun 30, 2017$170.38M–
Q2 FY2017CQ1 2017Mar 31, 2017$624.98M–
Q1 FY2017CQ4 2016Dec 31, 2016$399.99M–
Q4 FY2016CQ3 2016Sep 30, 2016$224.80M–

More Cencora figures

See a number that looks wrong?